267 related articles for article (PubMed ID: 12735420)
21. Hyperprolactinaemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction.
Venetikou MS; Lambou T; Gizani D
Andrologia; 2008 Aug; 40(4):240-4. PubMed ID: 18727734
[TBL] [Abstract][Full Text] [Related]
22. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
[TBL] [Abstract][Full Text] [Related]
23. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
[TBL] [Abstract][Full Text] [Related]
24. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
25. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
Serri O; Robert F; Comtois R; Jilwan N; Beauregard H; Hardy J; Somma M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of dynamic pituitary function testing in patients with hyperprolactinemia on diagnosis of pituitary prolactin-secreting adenoma (author's transl)].
Matsuura K
Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):569-78. PubMed ID: 6806416
[TBL] [Abstract][Full Text] [Related]
27. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
Rea N; Bove F; Gentile A; Parmeggiani U
Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of the thyrotrophin-releasing hormone stimulation test in paediatric clinical practice.
Crofton PM; Tepper LA; Kelnar CJ
Horm Res; 2008; 69(1):53-9. PubMed ID: 18059084
[TBL] [Abstract][Full Text] [Related]
29. [Pregnancy in hyperprolactinemic patients].
Ventz M; Puhlmann B; Knappe G; Gerl H; Lehmann R; Rohde W
Zentralbl Gynakol; 1996; 118(11):610-5. PubMed ID: 9082694
[TBL] [Abstract][Full Text] [Related]
30. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography.
Shangold GA; Kletzky OA; Marrs RP; Mishell DR
Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715
[TBL] [Abstract][Full Text] [Related]
31. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
32. [The combined stimulation test sulpiride-TRH in the investigation of prolactin secretion].
Miras-Mirakian P; Claustrat F; Dechaud H; Pugeat M
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(4):419-23. PubMed ID: 1624729
[TBL] [Abstract][Full Text] [Related]
33. [Basal and stimulated secretion of prolactin and growth hormone in patients with chronic uremia].
Rudolf K; Kunkel S; Rudolf H; Falkenhagen D; Rüting M
Zentralbl Gynakol; 1988; 110(11):693-7. PubMed ID: 3137737
[TBL] [Abstract][Full Text] [Related]
34. The value of pituitary magnetic resonance imaging in men with hypogonadism.
Rhoden EL; Estrada C; Levine L; Morgentaler A
J Urol; 2003 Sep; 170(3):795-8. PubMed ID: 12913700
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of hypothalamic hyperprolactinemia.
Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
[TBL] [Abstract][Full Text] [Related]
36. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL
Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
[TBL] [Abstract][Full Text] [Related]
37. [Reversible blindness caused by an invasive prolactinoma].
Schöfl-Siegert B; Brabant G; von zur Mühlen A; Schöfl C
Dtsch Med Wochenschr; 2001 May; 126(21):621-4. PubMed ID: 11413749
[TBL] [Abstract][Full Text] [Related]
38. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
[TBL] [Abstract][Full Text] [Related]
39. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease.
Peillon F; Dupuy M; Li JY; Kujas M; Vincens M; Mowszowicz I; Derome P
J Clin Endocrinol Metab; 1991 Nov; 73(5):1008-15. PubMed ID: 1939514
[TBL] [Abstract][Full Text] [Related]
40. Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
Ghigo E; Ciccarelli E; Bianchi SD; Gatti G; Molinatti GM; Massara F; Müller EE; Camanni F
Acta Endocrinol (Copenh); 1986 May; 112(1):20-7. PubMed ID: 3087130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
